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This study evaluates X-ray exposure in patient undergoing abdominal extra-vascular interventional procedures by means of
Digital Imaging and COmmunications in Medicine (DICOM) image headers and Monte Carlo simulation. The main aim was
to assess the effective and equivalent doses, under the hypothesis of their correlation with the dose area product (DAP) measured
during each examination. This allows to collect dosimetric information about each patient and to evaluate associated risks
without resorting to in vivo dosimetry. The dose calculation was performed in 79 procedures through the Monte Carlo simulator
PCXMC (A PC-based Monte Carlo program for calculating patient doses in medical X-ray examinations), by using the real
geometrical and dosimetric irradiation conditions, automatically extracted from DICOM headers. The DAP measurements
were also validated by using thermoluminescent dosimeters on an anthropomorphic phantom. The expected linear correlation
between effective doses and DAP was confirmed with an R2 of 0.974. Moreover, in order to easily calculate patient doses, conver-
sion coefficients that relate equivalent doses to measurable quantities, such as DAP, were obtained.
INTRODUCTION
Over the past decade, expansion of the X-ray imaging
has been dramatic, especially for computed tomog-
raphy (CT), angiography and interventional procedures
that give the largest contribution to the total collective
dose from all X-ray examinations.
In particular, interventional radiology (IR) proce-
dures are profoundly different from diagnostic radi-
ology exams due to their therapeutic purpose, which
can shift the risk–benefit ratio for radiation exposure(1).
Therefore, there is a significant concern related to the
risk of radiation-induced cancer in patients undergoing
fluoroscopically guided interventional procedures(2).
In radiation protection and radiology, effective
dose (E) and equivalent dose (HT) still provide a good
evaluation of the cancer risk to a whole or part of or-
ganism due to ionising radiation delivered non-uni-
formly to the part(s) of its body(3). Indeed, patient
dose report is currently considered the main tool for
the medical physicists to optimise the dose released
during IR procedures according to the clinical aim.
Differently from other examinations, interventional
procedures may have high variability according to the
type of X-ray equipment, the body region and the
kind and complexity of intervention. In particular,
non-vascular procedures may be repeated and may need
multiple fluoroscopy controls, also over a long-time
follow-up. As exposure conditions vary considerably
throughout a single procedure and X-rays exposure
could be prolonged, a patient-specific dosimetry is both
necessary and difficult(4). Furthermore, dosimetric as-
sessment is mandatory as recommended by the Council
Directive 2013/59/EURATOM, which lays down basic
safety standards for protection against the dangers
arising from exposure to ionising radiation.
The dose delivered to a patient during an interven-
tional procedure can be evaluated a posteriori by
using several methods. On one side, entrance surface
dose (ESD) may be measured by using Gafchromic
films and thermo-luminescent dosemeters (TLDs)
placed on the surface of a patient or a phantom (simu-
lating the part of an average patient under examin-
ation). On the other side, Monte Carlo simulations
applied on mathematical phantoms have been devel-
oped to evaluate E and HT by modelling the energy
deposition in the human body.
Many studies evaluated the ESD and its relation
with skin injuries and adverse tissues reactions, which
are related to deterministic effects, for both vascular
and non-vascular interventional procedures(5–7). In
particular, the complexity of non-vascular procedures
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and the related high exposure times led to investigate
the associated radiation exposure. Kloeckner et al.(8)
analysed the overall radiation dose released during non-
vascular interventions as biliary procedures, embolisa-
tions and percutaneous collection drainages. Karavasilis
et al.(9) and Stratakis et al.(10) reported equivalent
organs doses associated to biliary drainage proce-
dures; according to the latter, the organs receiving the
higher amount of radiations doses were the lumbar
spine, kidneys and adrenals.
Despite of these studies, the effective dose and the
abdominal organs equivalent doses have not yet well
investigated for some other classes of non-vascular
abdominal procedures. The main aim of the present
study was to estimate patient-specific radiation doses
in a group of abdominal extra-vascular interventions
using geometric and dosimetric irradiation data
automatically extracted from the DICOM header of
each examination. Moreover, coefficients to convert
dose area product (DAP) to equivalent doses and ef-
fective doses were evaluated in order to easily relate
the dosimetric quantities E and HT to a measurable
quantity.
MATERIALS ANDMETHODS
In the current study, a total of 49 patients who underwent
79 non-vascular interventional procedures in an IR
institution were included and analysed. This study met
the criteria of the Declaration of Helsinki and was
carried out with the informed consent of all patients. The
selected procedures were urinary system interventions
(unilateral, bilateral nephrostomy, fluoroscopic control
of nephrostomy, urinary stents management), liver/
biliary interventions [percutaneous cholangiography
(PTC), unilateral or bilateral biliary drainage placement,
biliary stent placement, cholecystectomy, fluoroscopic
controls of those procedures], drainage of abscess, fluid
collections and subsequent fluoroscopic controls. These
procedures represent the clinical routine in the institu-
tion and were performed by three experienced inter-
ventional radiologists (with 4, 15 and 30 years of
experience, respectively). The studied interventions
were divided into categories according to the type of
intervention (urinary procedures, biliary procedures
and collection drainages), Table 1, and to the abdomin-
al region involved (epigastric region and adjacent
ones, umbilical region and adjacent ones, hypogastric
region and adjacent ones), Table 2.
This separation into categories was necessary to
identify the main organs at risk based on the type of
intervention and the region involved.
The X-ray imaging system used in this study was the
Angiographer Siemens Artis Zee (Siemens, Erlangen,
Germany) with a large-area (30` ! 40 cm2) flat-panel Si
detector with CsI as scintillation material. An inherent
filtration of 2.5 mmAl and a tube voltage ranged from
71 to 81 kVp, through automatic exposure control,
Table 1. Patient data for each intervention.
Urinary Biliary Drainage of collections
Number of procedures 14 22 43
Patient number 7 16 26
Gender (M:F) 5:2 11:5 13:13
Age, ya 60.4+5.4 65.0+6.9 60.8+11.5
Height, cma 173.5+5.0 172.8+5.5 167.8+8.5
Weight, kga 82.2+10.4 72.0+8.3 67.1+12.4
BMI, kg m22a 27.4+3.9 24.0+2.6 24.0+3.2
aMean+SD.
Table 2. Patient data for each district.
Epigastric region and adjacent Umbilical region and adjacent Hypogastric region and adjacent
Number of procedures 31 24 24
Patient number 23 19 17
Gender (M:F) 16:7 13:6 8:9
Age, ya 69.4+9.8 60.0+7.1 60.8+11.6
Height, cma 171.0+7.2 171.4+5.3 169.6+9.3
Weight, kga 69.4+9.8 75.3+11.7 73.6+16.1
BMI, kg m22a 23.8+2.3 25.9+4.0 25.9+4.4
aMean+SD.
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were used. Both radiography and fluoroscopy (10 pulses
per second with a pulse width of 15 ms) were recorded,
while the field size varied with the collimators position.
For all procedures, the same low-radiation-exposure
protocol was used in order to guarantee a standard for
all X-ray examinations.
According to the recent European guidelines, all
newly installed radiological devices have to provide
an indication of patient dose. In digital X-ray equip-
ment, this indication could be given in terms of DAP
or entrance air kerma (EAK), which are automatically
stored in the DICOM header image files or in a system
report file. In order to provide a DAP indication, the
used angiographer is equipped with a calibrated air
ionisation chamber DAP meter, incorporated in the
tube housing. The system provides a readout of the cu-
mulative DAP for every image run and the EAK,
which is calculated from the measured DAP at a specif-
ic point, called intervention reference point (IRP) and
located at 63.5 cm from the X-ray source.
To ensure that the system was properly calibrated,
i.e. the DAP and EAK values provided by the device
were accurate, a set of experimental measurements
were previously performed. The angiographer ionisation
chamber accuracy was verified using an external cali-
brated DAP meter (DAP/dose meter KermaX plus
TinO IDP), while the correctness of the EAK pro-
vided by the angiographic system was validated by
performing ESD measurements with TLDs on the
Anderson-Rando anthropomorphic phantom. For
this purpose, TLDs (LiF100) were applied on the
prone phantom abdomen at the centre of the radi-
ation field (Figure 1).
The TLDs were irradiated at different exposures levels,
varying the exposure time (6, 8, 10 and 12 min) with an
X-ray field of 25`! 25 cm2 at 70 kVp; these dosemeters
measured the personal dose equivalent Hp (0.07). The
ESD values resulting from TLD reading were compared
with the ESD calculated from the EAK provided by the
system report file. As the angiographer provides the EAK
at the IRP without the backscatter contribution, the fol-
lowing correction has to be applied:
ESD = EAKIRP ! BSF! SSDSRD
! "2
; ð1Þ
where SSD and SRD represent the source-to-surface and
the source-to-reference point distances, respectively, while
BSF is the backscatter factor that arises from the radi-
ation backscattered from the phantom. Equation 1
allows to scale the EAK at the plane where TLD is
placed, and it is valid under conditions of electron equi-
librium, which can be assumed to apply to low-energy
and medium-energy X-ray beams at the depth 0.07 mm,
i.e. the measuring depth of the personal dose equivalent
Hp (0.07).
An automated method to extract patient (weight and
height), exposure, geometric and dosimetric (DAP or
EAK) parameters from the headers of DICOM image
files was developed in the MATLAB (MathWorks,
Natick, MA) environment and applied to the sets of the
present study examinations. These extracted data were
then used as input for the Monte Carlo simulator
PCXMC (STUK, Finland, Servomaa and Tapiovaara
1998).
This program allows a free adjustment of the X-ray
beam direction and other examination conditions of
projection in radiographic and fluoroscopic irradiation.
Parameters such as X-ray tube voltage (kVp), total
beam filtration, focus to skin distance (FSD), degrees
rotation around the patient’s longitudinal axis and in
craniocaudal direction, skin entry point of the central
beam axis (in terms of coordinates xref, yref and zref )
and field size (Askin) at this position had to be provided.
These parameters allowed simulating the real
Figure 1. Experimental validation setting.
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irradiation conditions of patients during each proced-
ure. In order to calculate the effective and the equiva-
lent doses, the program uses the DAP (in mGy cm2)
value or alternatively the EAK, in mGy and without
backscatter, reported in the DICOM header of image
files. The developed MATLAB software allows to
automatically extract all the mentioned data from the
DICOM headers of each examination. In particular,
X-ray tube voltage (kVp), total beam filtration, FSD,
and degrees of rotation about the main axis were dir-
ectly extracted from DICOM tags, while the field size
Askin was calculated by the software using collimator
positions and imager pixel size extracted from respect-
ive tags(11):
Askin ¼
#
ðjCL % CRj! p10
$ %
! ðjCT % CBj! p10
$ %&
! SPD
SID
! "
; ð2Þ
where CL, CR, CT and CB are the collimator positions
in pixels in left, right, top and bottom, respectively,
and p is the imager pixel size in mm. SPD and SID re-
present the source-to-patient and the source-to-image
distances, respectively.
Moreover, in order to identify the organs really
covered by the irradiation field, it is necessary to identify
the central location of the field. As a matter of fact, as
the skin entry point of the central beam axis depends on
the irradiation conditions (patient position, orientation
of the C arm), the coordinates xref, yref and zref were
identified according to division of the abdomen into nine
regions. The coordinates xref and zref corresponded to
the centres of these regions, thus ensuring a better dose
evaluation for the organs covered by the X-ray field. A
linear regression analysis was performed to explore the
correlations between DAP and effective doses or equiva-
lent doses to abdominal organs. For all fitting procedures,
the correlation coefficients R2 were calculated in order to
take into account the goodness of fits.
RESULTS
Firstly, the validation of DAP and EAK provided by
the angiographer is discussed. The DAP values, mea-
sured and provided by the angiographer, agree within
the expected range of values. Moreover, the compari-
son between the ESDs, measured (by TLD dose-
meters) and calculated using the EAK extracted from
the system report file, is in agreement (Figure 2) within
the reported overall uncertainty of the TLDmethod.
Secondly, equivalent doses for the organs included
in the radiation field were evaluated according to the
involved region (epigastric region and adjacent ones,
umbilical region and adjacent ones, hypogastric
region and adjacent ones). A linear fit of the equiva-
lent doses as function of DAP was performed for
such districts. Table 3 presents the DAP range, the
results of simulation (equivalent dose range, its mean
value and standard error) and the results of statistical
analysis (conversion coefficients C between DAP and
equivalent doses for abdominal organs, in mSv Gy21
cm22, and the resulting R2).
This analysis shows that it is possible to deduce HT
from DAP by using the appropriate conversion coeffi-
cients, although somewhere with aweaker correlation.
As it can be seen in Table 3, for the procedures per-
formed at the level of the upper quadrants (epigastric
regions and adjacent zones), the organs mostly
exposed to radiations were the kidneys (mean equiva-
lent dose HT of 41.7 mSv), gallbladder (HT of 7.5
mSv) and adrenals (HT of 7.1 mSv). In the mid-
quadrants, higher equivalent doses were delivered to
the small intestine (HT of 9.6 mSv), active bone
marrow (HT of 9.2 mSv), kidneys (HT of 5.6 mSv)
and colon (HT of 5.1 mSv). In the lower quadrants,
higher radiation doses were delivered to the urinary
bladder (HT of 5.0 mSv), colon (HT of 3.7 mSv) and
active bone marrow (HT of 3.7 mSv).
Moreover, the mean equivalent doses were investi-
gated for the three subgroups that represent the different
type of interventions. The calculated mean equivalent
dose values related to the organs receiving considerable
amounts of radiation doses, for urinary procedures,
biliary procedures and collection drainages, respectively,
are presented through the histogram of Figure 3.
Furthermore, as expected, the study confirmed a
linear correlation between DAP (device output reported
on DICOM tags) and effective dose (simulation
output), Figure 4, with an R2 of 0.974. The linear fit
of E as function of DAP resulted in a conversion coef-
ficient of 0.089+0.009 mSv Gy21 cm22. This conver-
sion coefficient allows to directly evaluate E from
the DAP, provided in the system report file, without
resorting to in vivo dosimetry.
DISCUSSION
The presented method allowed defining and analysing
the X-ray dose released to patients undergoing extra-
vascular examinations without resorting to in vivo dos-
imetry. Monte Carlo simulation (PCXMC code) was
used in conjunction with DAP measurements in order
to estimate both HT and E for each examination. The
confirmed linear correlation between DAP and effective
dose represents an important tool to directly deduce
E from DAP for each patient. Nowadays, the recom-
mended dose levels are referred to DAP value, which is
the most common measureable dose indicator(12–14).
The UK National Patient Dose Database (NPDD) pro-
vided the latest set of European reference doses for eight
interventional procedures, in terms of both total DAP
and total fluoroscopy time(15). Also other authors pro-
posed reference levels for some non-vascular interven-
tional procedures (biliary drainages, nephrostomies)(16).
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According to these references, biliary interventions have
the highest reference dose (50 Gy cm2) of all procedures.
Otherwise, the DAP-recommended limit for nephros-
tomies is 14 Gy cm2, while the limits for drainages
of collection are not provided. The biliary procedures
studied in this article had overcome the recommended
threshold in the 20 % of cases. For urinary interventions
(unilateral, bilateral nephrostomy, fluoroscopic control
of nephrostomy, urinary stents management), it is not
possible to provide a similar comparison, because the
recommended limit is provided for nephrostomies only.
The main advantages of the proposed method
lie in the possibility to take into account the high
variability of the studied procedures, as it uses for
Table 3. DAP range, results of simulation and statistical analysis for each district.
DAP range
(Gy cm2)
HT range
(mSv)
HT (mSv)a C (mSv
Gy21 cm22)
R2
Epigastric region and
adjacent ones
1.75–76.25 Active bone
marrow
0.15–13.92 3.01+0.13 0.123 0.750
Adrenals 0.38–42.73 7.07+0.30 0.275 0.675
Colon 0.16–10.19 3.18+0.11 0.123 0.966
Gall bladder 0.17–35.90 7.47+0.31 0.297 0.766
Kidneys 1.47–150.10 41.73+1.59 1.653 0.897
Liver 0.06–32.57 6.29+0.30 0.237 0.483
Pancreas 0.17–22.31 5.23+0.22 0.275 0.675
Skin 0.12–6.84 2.37+0.08 0.090 0.991
Small intestine 0.26–19.10 5.04+0.18 0.196 0.933
Spleen 0.02–59.71 7.31+0.44 0.226 0.103
Stomach 0.03–15.22 3.04+0.15 0.109 0.370
Umbilical region and
adjacent ones
1.78–249.06 Active bone
marrow
0.29–87.93 9.22+0.76 0.327 0.977
Colon 0.19–38.32 5.04+0.37 0.152 0.957
Gall bladder 0.06–6.94 1.98+0.09 0.039 0.420
Kidneys 0.34–26.03 5.60+0.31 0.121 0.428
Skin 0.14–29.36 3.33+0.26 0.115 0.989
Small intestine 0.32–75.11 9.63+0.66 0.298 0.978
Hypogastric region
and adjacent ones
1.48–198.20 Active bone
marrow
0.13–34.46 3.72+0.30 0.710 0.994
Colon 0.06–39.14 3.74+0.33 0.187 0.981
Skin 0.09–24.91 2.38+0.21 0.018 0.981
Small intestine 0.06–17.00 2.06+0.15 0.088 0.989
Urinary bladder 0.14–40.02 4.93+0.37 0.213 0.965
aOrgan equivalent doses are expressed in term of mean value and standard error.
Figure 2. Comparison between TLD and ESD values.
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simulation the real energy beam spectra, the real
geometric projection and distances, the actual
organs (or part of them) covered by the irradiation
field of each procedure.
CONCLUSION
The presented method that automatically extracts
DICOM information, complemented by the Monte
Carlo simulator PCXMC, is a feasible and promising
approach for easily monitoring patient dose and opti-
mising the IR procedures in order to limit the riskof sto-
chastic and deterministic effects. The presented method
allows to customise the dose calculation, in order to
produce a dosimetric report for each patient; this report
could be fundamental, especially for patients undergo-
ing repeated X-rays procedures. Finally, knowledge and
Figure 3. Histogram of mean organ equivalent doses per kind of intervention.
Figure 4. Relationship between effective dose and DAP values.
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easy calculation of the equivalent doses related to each
interventions contribute to collect patient-specific dosi-
metric information and to evaluate associated risks to
X-ray exposure according to the type of procedure.
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